[1] 吴军,尚瑞.茵陈水提物对牛血清白蛋白诱导的肝损伤小鼠的保护作用研究. 实用肝脏病杂志,2017,20(1):51-54. [2] 郑凯,李海. 降脂药物的合理应用与药物性肝损伤.实用肝脏病杂志,2017,20(2):139-141. [3] Xu T,Singh D,Liu J,et al.Neferine,is not inducer but blocker for macroautophagic flux targeting on lysosome malfunction. Biochem Biophys Res Commun,2018,495(1):1516-1521. [4] Priya LB,Baskaran R,Huang CY,et al.Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin:possible role in modulating NADPH oxidase/ROS-mediated NFκB redox signaling cascade. Sci Rep,2017,7(1):12283. [5] Zhang H,Jia R,Wang F,et al.Catalpol protects mice against lipopolysaccharide/D-galactosamine-induced acute liver injury through inhibiting inflammatory and oxidative response. Oncotarget,2017,9(3):3887-3894. [6] Choi YJ,Zhou D,Barbosa ACS,et al.Activation of constitutive androstane receptor ameliorates renal ischemia-reperfusion-induced kidney and liver injury. Mol Pharmacol,2018,93(3):239-250. [7] Shen CH,Tung SY,Huang WS,et al.Comparative proteomic identification of protein disulphide isomerase a6 associated with tert-butylhydroperoxide-induced liver injury in rat hepatocytes. Cell Physiol Biochem,2018,45(5):1915-1926. [8] Wang S,Wang J,Lyu X.Selection of reference genes for expression analysis in mouse models of acute alcoholic liver injury. Int J Mol Med,2018,41(6):3527-3536. [9] Riverso M,Chang M,Soldevila-Pico C,et al.Histologic characterization of kratom use-associated liver injury. Gastroenterol Res,2018,11(1):79-82. [10] Verdelho M,Perdigoto R,Machado J,et al.Acute-on-chronic liver failure:a portuguese single-center reference review. GE Port J Gastroenterol,2018,25(1):18-23. [11] Hage A,Chick JFB,Srinivasa RN,et al.Disseminated intravascular coagulation and acute liver injury from ethanol embolization of an arteriovenous malformation. J Vasc Interv Radiol,2018,29(3):437-439. [12] Jung JY,Park SM,Ko HL,et al.Epimedium koreanum ameliorates oxidative stress-mediated liver injury by activating nuclear factor erythroid 2-related factor 2. Am J Chin Med,2018,46(2):469-488. [13] Cheema HI,Gupta A.Levonorgestrel-releasing intrauterine device-related acute liver injury. Case Rep Gastroenterol,2017,11(3):742-747. [14] Verma N,Kumar P,Mitra S,et al.Drug idiosyncrasy due to pirfenidone presenting as acute liver failure:Case report and mini-review of the literature. Hepatol Commun,2017,2(2):142-147. [15] Yamashita YI,Imai K,Mima K,et al.Idiosyncratic drug-induced liver injury:A short review. Hepatol Commun,2017,1(6):494-500. [16] Lin Y,Li Y,Hu X,et al.The hepatoprotective role of reduced glutathione and its underlying mechanism in oxaliplatin-induced acute liver injury. Oncol Lett,2018,15(2):2266-2272. [17] Chiu YJ,Chou SC,Chiu CS,et al.Hepatoprotective effect of the ethanol extract of polygonum orientale on carbon tetrachloride-induced acute liver injury in mice. J Food Drug Anal,2018,26(1):369-379. [18] Giustarini G,Kruijssen L,van Roest M,et al. Tissue influx of neutrophils and monocytes is delayed during development of trovafloxacin-induced tumor necrosis factor-dependent liver injury in mice. J Appl Toxicol,2018,38(5):753-765. [19] Waseem N,Limketkai BN,Kim B,et al.Risk and prognosis of acute liver injury among hospitalized patients with hemodynamic instability:A nationwide analysis. Ann Hepatol,2018,17(1):119-124. [20] Bizzaro D,Crescenzi M,Di Liddo R,et al.Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury. Clin Sci (Lond),2018,132(2):255-272. |